A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction

American Heart Journal

Volumn 162, Issue 4, 2011, Pages

  Povsic, Thomas J ^a   O'Connor, Christopher M ^c   Henry, Timothy ^b   Taussig, Andrew ^c   Kereiakes, Dean J ^d   Fortuin, F David ^e   Niederman, Alan ^f   Schatz, Richard ^g   Spencer IV, Richard ^h   Owens, Douglas ^h   Banks, Missy ^a   Joseph, Diane ^a   Roberts, Rhonda ^a   Alexander, John H ^a   Sherman, Warren ⁱ  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c FLORIDA HOSPITAL   (United States)

^d CHRIST HOSPITAL   (United States)

^e MAYO CLINIC HOSPITAL   (United States)

^f The Jim Moran Heart and Vascular Research Institute   (United States)

^g SCRIPPS CLINIC   (United States)

^h Bioheart Inc   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKELETAL MYOBLAST TRANSPLANTATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 80053654714     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.07.020     Document Type: Article

References (29)

1. D. Lloyd-Jones, R.J. Adams, and T.M. Brown Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 2010 e46 215
2. D.W. Losordo, P.R. Vale, and R.C. Hendel Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia Circulation 105 2002 2012 2018 (Pubitemid 34465261)
3. T.D. Henry, C.L. Grines, and M.W. Watkins Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials J Am Coll Cardiol 50 2007 1038 1046 (Pubitemid 47354223)
4. T.D. Henry, B.H. Annex, and G.R. McKendall The VIVA trial: vascular endothelial growth factor in Ischemia for Vascular Angiogenesis Circulation 107 2003 1359 1365 (Pubitemid 36350732)
5. M. Galinanes, M. Loubani, and J. Davies Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans Cell Transplant 13 2004 7 13 (Pubitemid 38252708)
6. D. Orlic, J. Kajstura, and S. Chimenti Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci USA 98 2001 10344 10349 (Pubitemid 32803022)
7. C.E. Murry, M.H. Soonpaa, and H. Reinecke Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 664 668 (Pubitemid 38524810)
8. C. Bearzi, M. Rota, and T. Hosoda Human cardiac stem cells Proc Natl Acad Sci USA 104 2007 14068 14073 (Pubitemid 350003336)
9. A.P. Beltrami, L. Barlucchi, and D. Torella Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776 (Pubitemid 37186770)
10. R.R. Smith, L. Barile, and H.C. Cho Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens Circulation 115 2007 896 908 (Pubitemid 46294730)
11. S. Ghostine, C. Carrion, and L.C. Souza Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction Circulation 106 2002 I131 I136
12. D.A. Taylor, B.Z. Atkins, and P. Hungspreugs Regenerating functional myocardium: improved performance after skeletal myoblast transplantation Nat Med 4 1998 929 933 (Pubitemid 28364032)
13. B. Pouzet, J.T. Vilquin, and A.A. Hagège Factors affecting functional outcome after autologous skeletal myoblast transplantation Ann Thorac Surg 71 2001 844 850
14. K.L. He, G.H. Yi, and W. Sherman Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs J Heart Lung Transplant 24 2005 1940 1949 (Pubitemid 41641872)
15. P. Menasché, A.A. Hagège, and M. Scorsin Myoblast transplantation for heart failure Lancet 357 2001 279 280 (Pubitemid 32120862)
16. P. Menasché, A.A. Hagège, and J.T. Vilquin Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J Am Coll Cardiol 41 2003 1078 1083 (Pubitemid 36384891)
17. N. Dib, P. McCarthy, and R. MacLellan Two-year follow-up of the feasibility and safety of autologous myuoblast transplantation for ischemic cardiomyopathy in patients undergoing coronary artery bypass grafting (abstract) Circulation 110 2004 III 51
18. P.C. Smits, R.J. van Geuns, and D. Poldermans Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up J Am Coll Cardiol 42 2003 2063 2069 (Pubitemid 37549885)
19. W. Sherman, T. Henry, and N. Chronos Results of the MYOHEART Trial: a phase 1 study of skeletal myoblasts in patients with congestive heart failure Paper presented at: Transcatheter Cardiovascular Therapeutics (TCT); October, Washington, DC 2007
20. P. Menasche, O. Alfieri, and S. Janssens The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200 (Pubitemid 351552018)
21. P. Serruys Final results of a phase II-a, randomized, open-label trial to evaluate intramyocardial autologous skeletal myoblast transplantation in congestive heart failure patients: the SEISMIC trial Paper presented at: the American College of Cardiology 57th Annual Scientific Session; March, Chicago, IL 2008
22. N. Dib, J. Dinsmore, and Z. Lababidi One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC Study) JACC: Cardiovasc Intervent 2 2009 9 16
23. W.R. Mills, N. Mal, and M.J. Kiedrowski Stem cell therapy enhances electrical viability in myocardial infarction J Mol Cell Cardiol 42 2007 304 314 (Pubitemid 46135598)
24. W. Sherman MYOHEART US phase I study: 12 month data Paper presented at: the Fifth Annual Conference on Cell Therapy for Cardiovascular Disease; January, New York, NY 2008
25. T. Siminiak, R. Kalawski, and D. Fiszer Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up Am Heart J 148 2004 531 537 (Pubitemid 39265130)
26. J.P. Piccini, J.S. Berger, and C.M. O'Connor Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials Eur Heart J 30 2009 1245 1253
27. + cell therapy for refractory angina Paper presented at: the American College of Cardiology 58th Annual Scientific Session/i2 Summit; March, Orlando, FL 2009
28. D.W. Losordo, R.A. Schatz, and C.J. White Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial Circulation 115 2007 3165 3172 (Pubitemid 47018140)
29. J. van Ramshorst, J.J. Bax, and S.L. Beeres Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial JAMA 301 2009 1997 2004